China Universal Asset Management »

Amylyx Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $37k 13k 2.85
2023-12-31 $115k 7.8k 14.72
2023-09-30 $32k 1.7k 18.50
2023-06-30 $19k 880 21.59
2023-03-31 $26k 897 28.99
2022-12-31 $25k 673 37.15

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
BlackRock
Viking Global Investors
Point72 Asset Management
Millennium Management
Citadel Advisors
Ikarian Capital
Perceptive Advisors
Susquehanna International
Franklin Resources
Goldman Sachs Group
Jane Street
Eventide Asset Management
Marshall Wace
Citigroup

View all funds holding Amylyx Pharmaceuticals